GlassScriptPhysician profile
Marc J Rosenberg
NPI 1699808121
$5,879.59
in general payments reported to CMS, 2019-2025
36 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,391 · 2020: $427 · 2021: $847 · 2022: $1,573 · 2023: $1,059 · 2024: $193 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399 · Travel and Lodging: $147 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.64 |
| Travel and Lodging | $147.37 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,053.54 | 2019-2023 | |
| Medtronic, INC. | $645.40 | 2021-2025 | Selectsecure, Azure Xt Dr Mri Surescan, Linq II |
| Janssen Pharmaceuticals, INC | $601.21 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.96 | 2019-2023 | Jardiance |
| Amgen INC. | $429.89 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $405.24 | 2021-2023 | Verquvo |
| Boston Scientific Corporation | $265.56 | 2019-2025 | Accolade Sr, Peripheral Rotalink Plus, Ekosonic |
| Pfizer INC. | $196.76 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.97 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $160.88 | 2022-2023 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $155.21 | 2019-2023 | Farxiga |
| Cardiovascular Systems INC. | $143.28 | 2019-2023 | Diamondback Coronary |
| Medtronic Vascular, INC. | $131.97 | 2019-2020 | |
| Philips North America LLC | $123.08 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck6) Holter |
| Astellas Pharma US INC | $110.48 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $106.16 | 2019-2023 | Eliquis |
| Regeneron Healthcare Solutions, INC. | $103.64 | 2019 | |
| Esperion Therapeutics, INC. | $96.69 | 2020-2022 | |
| Amarin Pharma, INC. | $67.17 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $59.10 | 2019 | |
| Sanofi-Aventis U.S. LLC | $58.61 | 2019-2022 | |
| Vital Connect, INC | $54.99 | 2024-2025 | Vitalpatch Rtm |
| Shockwave Medical, INC | $40.20 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $37.18 | 2023 | Ozempic, Rybelsus |
| Terumo Medical Corporation | $31.38 | 2019-2020 | |
| Abiomed | $30.32 | 2025 | |
| Daiichi Sankyo INC. | $26.91 | 2023 | Injectafer |
| Abbott Laboratories | $23.83 | 2023 | Assurity |
| Ethicon US, LLC | $22.56 | 2025 | Vistaseal, Surgicel Nu-Knit |
| Biotronik INC. | $22.31 | 2019 | |
| Elutia, INC. | $16.54 | 2021 | |
| W. L. Gore & Associates, INC. | $13.03 | 2020 | |
| Penumbra, INC. | $12.72 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.72 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.68 | 2021 | |
| Teleflex LLC | $11.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.